US Patent Issued to The Research Foundation for The State University of New York, Rosalind Franklin University of Medicine and Science, Board of Trustees of Michigan State University on April 29 for "Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia" (New York, Michigan, Illinois Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,426, issued on April 29, was assigned to The Research Foundation for The State University of New York (Binghamton, N.Y.), Rosalind Franklin University of Medicine and Science (North Chicago, Ill.) and Board of Trustees of Michigan State University (East Lansing, Mich.).

"Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia" was invented by Christopher Roy Bishop (Vestal, N.Y.), Anthony West (North Chicago, Ill.) and Fredric Manfredsson (Grand Rapids, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating and attenuating L-DOPA-induced dyskinesia, comprisi...